TENODAX-M FORTE Tablets provide an established, clinically unified combination anti-hyperglycemic therapy carefully developed for the continuous management and physiological stabilization of Type 2 Diabetes Mellitus. When standard monotherapies fail to contain progressive insulin resistance and pancreatic beta-cell fatigue, attacking metabolic dysfunction through independent, highly complementary physiological loops becomes vital. This advanced formulation integrates a modern dipeptidyl peptidase-4 inhibitor with a high-dose sustained-release biguanide within a single unit, maximizing peripheral glucose utilization and stabilizing natural incretin hormones safely over a long-term care routine.
The synchronized formulation operates dynamically across two distinct metabolic fronts:
-
Teneligliptin (20 mg): A potent, selective dipeptidyl peptidase-4 (DPP-4) inhibitor. It works by blocking the degradation of endogenous incretin hormones, namely glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). This physical blockade prolongs incretin activity, prompting the pancreas to increase glucose-dependent insulin secretion while simultaneously suppressing inappropriate glucagon release.
-
Metformin HCL (1000 mg SR): A foundational biguanide presented in a specialized sustained-release matrix. It targets the roots of insulin resistance by reducing hepatic gluconeogenesis (glucose production in the liver), decreasing intestinal glucose absorption, and enhancing peripheral insulin sensitivity by activating AMP-activated protein kinase (AMPK) pathways to accelerate glucose uptake across skeletal muscle structures around the clock.
Key Benefits
-
Advanced Dual Metabolic Control: Unites an incretin stabilizer with an intensive 1000 mg insulin sensitizer to manage stubborn blood sugar levels efficiently.
-
Sustained-Release Gastro Protection: The advanced Metformin matrix releases active elements slowly over an extended period, significantly dropping the tracking risk of gastrointestinal irritation.
-
Smart Insulin Optimization: Teneligliptin triggers pancreatic insulin release exclusively when blood glucose levels are high, drastically minimizing the statistical risk of sudden drops (hypoglycemia).
-
Robust Fasting & Post-Meal Shield: Effectively manages post-meal blood sugar surges while continuously keeping overnight hepatic glucose leaks under control.
-
Trusted Quality: Manufactured under high-standard pharmaceutical protocols of DH, ensuring exceptional dissolution uniformity and long-term chemical stability.
Directions for Use
-
Take exactly as directed by your diabetologist, endocrinologist, or primary healthcare physician.
-
TENODAX-M FORTE must strictly be taken orally with or immediately after a main meal (preferably with your morning breakfast or evening dinner). Administering it alongside food optimizes absorption tracking and shields the gastric lining from initial compound changes.
-
Swallow the tablet whole with a full glass of plain water. Do not crush, break, split, or chew it, as doing so will destroy the specialized sustained-release matrix and cause rapid medicine dumping.
-
Maintain complete daily consistency alongside a structured low-glycemic diet and active tracking routines; missing doses can cause blood sugar levels to spike rapidly behind tracking boundaries.
Safety & Precautions
-
Do not modify your dose or halt usage suddenly without professional medical clearance, as blood sugar levels can destabilize rapidly.
-
Lactic Acidosis Warning: Although rare, Metformin accumulation can trigger a serious metabolic complication known as lactic acidosis. The risk increases with heavy chronic alcohol consumption, severe kidney impairment, or dehydration. Inform your specialist before initialization if you have underlying renal filtration updates or hepatic vulnerabilities.
-
Monitor your blood glucose baselines, HbA1c levels, and renal function parameters (serum creatinine / eGFR) regularly throughout long-term care.
-
Hypoglycemia Signs: While this combination is highly secure, using it alongside duplicate antidiabetic therapies (like sulfonylureas or insulin) can cause blood sugar to drop. Always carry a quick source of glucose or candy if you track symptoms like sudden cold sweating, deep shakiness, dizziness, or intense hunger.
-
Keep out of reach of children.
Storage
-
Store in a cool, dry place below 30°C.
-
Protect from direct sunlight, excessive heat sources, and environmental room moisture pools.
-
Always keep the tablets safely sealed inside their original protective blister packaging layout until the exact moment of intake to shield the core components from ambient room humidity.
